Eckert & Ziegler To Supply Actinium Pharmaceuticals With AC-225 For Comprehensive Development Activities
Reuters
Mar 25, 2025
March 25 (Reuters) - ECKERT & ZIEGLER SE :: *TO SUPPLY ACTINIUM PHARMACEUTICALS WITH AC-225 FOR COMPREHENSIVE DEVELOPMENT ACTIVITIES *ACTINIUM PHARMACEUTICALS TO FURTHER DEVELOP ACTIMAB-A AS WELL AS ADDITIONAL EARLY AND LATE-STAGE DEVELOPMENT CANDIDATES FOR BOTH U.S. AND INTERNATIONAL CLINICAL TRIALS
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.